Clinical trial NCT04274036: Evaluation of Stigma and Related Factors in Fibromyalgia
Official title: Evaluation of Stigma and Related Factors in Fibromyalgia Patients
Study type: OBSERVATIONAL
Overall status: UNKNOWN
Conditions: Fibromyalgia
Keywords: Fibromyalgia
Social Support
Stigma
Lead sponsor: Gaziosmanpasa Research and Education Hospital
Sponsor class: OTHER_GOV
First posted: 2020-02-18
Enrollment: 108
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Observational model: CASE_CONTROL
Time perspective: CROSS_SECTIONAL
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Fibromiyalgia patients and healthy controls with an allocation ratio of 2:1.

Brief summary: Stigmatization is especially studied in mental disorders such as schizophrenia. In recent years, different chronic diseases such as AIDS, tuberculosis, and diabetes have also been shown to decrease in quality of life due to the "stigma" of these patients.

Detailed description: Stigmatization is especially studied in mental disorders such as schizophrenia. In recent years, different chronic diseases such as AIDS, tuberculosis, and diabetes have also been shown to decrease in quality of life due to the "stigma" of these patients. Fibromyalgia patients with chronic widespread body pain and accompanying subjective fatigue, depression, and anxiety; Although there is no objective pathology from the outside, it can be stigmatized in family life, work-life and health institutions they apply for the diagnosis of pain due to the intensive complaints. The fact that the subjective complaints seen without an objective pathology are so severe makes the management of these patients difficult. To reveal the presence of stigma in patients diagnosed with fibromyalgia compared with the healthy control group is the main aim of this study. It is the secondary purpose of this study to determine related factors such as gender, age, educational status, marital status, employment status, income level, pain duration, pain intensity, medications used, and social support received from patients' family and the environment. We hypothesize that this group of patients suffers more stigma and the quality of life decreases due to this stigma.

Eligibility criteria: Inclusion Criteria:

* Patients over the age of 18
* To be diagnosed with fibromyalgia according to American College of Rheumatology 2016 revised criteria

Exclusion Criteria:

* Have been diagnosed and treated with fibromyalgia before
* Presence of any diagnosis that can cause secondary fibromyalgia (rheumatic diseases such as rheumatoid arthritis, ankylosing spondylitis)
* The presence of anemia
* Vitamin D deficiency
* Presence of known endocrine, neurological and cardiac diseases
* Antidepressant use

Primary outcomes:
measure: Visual Analog Scale
timeFrame: Baseline
measure: Discomfort Intolerance Scale
timeFrame: Baseline
measure: The Distress Tolerance Scale
timeFrame: Baseline
measure: Fibromyalgia Impact Questionnaire - Revised
timeFrame: Baseline
measure: Stigma Scale for Chronic Illness
timeFrame: Baseline
Secondary outcomes:
Other outcomes:
Locations:
city: Istanbul
country: Turkey
facility: Gaziosmanpasa Taksim Research and Education Hospital
Study officials:
References: